ENLV
-EXO-CD24 was tested on Covid patients at Ichilov Medical Center in Tel Aviv-
-Some 29 out of 30 patients suffering moderate to severe conditions recovered
-Drug was developed to treat cancer by regulating immune system responses
-Some 29 out of 30 patients suffering moderate to severe conditions recovered
-Drug was developed to treat cancer by regulating immune system responses
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.